GMP certified site
Provepep develops pharmaceutical grade peptides and proteins from all stages of drug development to manufacturing.
Read more: Our offer
Provepep’s unique native ligation SEA technology used in chemical synthesis of long peptides and proteins.
Marseille, France, October 5, 2015 - Provepep, the peptide business unit of Provence Technologies Group, a specialist fine chemistry research group, today announces that it has successfully synthesized tens of mg of bioactive homodimer form of IL-10. Read more: October 2015: Provepep performs first-ever synthesis of bioactive homodimer form of IL-10
Provepep possesses a unique technology of native ligation SEA, allowing us to offer an alternative to recombinant technology with an efficient, qualitative and cost-effective solution.
Read more: Patented technology